A
Andrea Rubboli
Researcher at Loyola University Medical Center
Publications - 133
Citations - 2815
Andrea Rubboli is an academic researcher from Loyola University Medical Center. The author has contributed to research in topics: Percutaneous coronary intervention & Atrial fibrillation. The author has an hindex of 23, co-authored 111 publications receiving 2454 citations.
Papers
More filters
Journal ArticleDOI
Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial.
Heli Lahtela,Tuomas Kiviniemi,Marja Puurunen,Axel Schlitt,Andrea Rubboli,Antti Ylitalo,José Valencia,Gregory Y.H. Lip,K.E. Juhani Airaksinen +8 more
TL;DR: Renal impairment is common in patients with AF undergoing PCI and even mild renal impairment has an adverse prognostic effect in these patients requiring multiple antithrombotic medications, according to an adjusted a Cox regression model.
Journal ArticleDOI
Acute Total Occlusion of the Right Coronary Artery by a Pellet
TL;DR: A 78-year-old man was hospitalized because of chest pain that had started 2 hours earlier while rifle shooting, and physical examination revealed no abnormalities, except for a wound at the jugular notch, presumably due to the entrance of …
Journal ArticleDOI
Antithrombotic management of patients with acute coronary syndrome and atrial fibrillation undergoing coronary stenting: a prospective, observational, nationwide study.
Leonardo De Luca,Andrea Rubboli,Leonardo Bolognese,Lucio Gonzini,Stefano Urbinati,Adriano Murrone,Fortunato Scotto di Uccio,Fabio Ferrari,Fabiana Lucà,Pasquale Caldarola,Donata Lucci,Domenico Gabrielli,Andrea Di Lenarda,Michele Massimo Gulizia,Matador-Pci Investigators +14 more
TL;DR: In this article, the authors assess current management of patients with atrial fibrillation (AF) and acute coronary syndrome (ACS) undergoing coronary stent implantation and find that triple antithrombotic therapy (TAT) was prescribed in 64.8%, dual antiplatelet therapy (DAPT) was less often used (11.2% vs 39.5% vs 5.3%, respectively; both p<0.0001).
Journal ArticleDOI
Detection of myocardial fibrosis by speckle-tracking echocardiography: from prediction to clinical applications
Matteo Lisi,Matteo Cameli,Giulia Elena Mandoli,Maria Concetta Pastore,Francesca Maria Righini,Flavio D'Ascenzi,Marta Focardi,Andrea Rubboli,Sergio Mondillo,Michael Y. Henein +9 more
TL;DR: An overview of the pathophysiology of MF and the clinical application of echocardiographic techniques for the prediction of left and right heart chambers MF in HF patients is provided.
Journal ArticleDOI
New-generation drug-eluting stents reduce stent thrombosis and myocardial infarction: a propensity-score-adjusted analysis from the multicenter REAL registry (REgistro Regionale AngiopLastiche Dell'Emilia-Romagna).
Luigi Vignali,Francesco Saia,Laura Maria Beatrice Belotti,Emilia Solinas,Paolo Guastaroba,Andrea Rubboli,Antonio Manari,Roxana Mehran,Diego Ardissino,Rossana De Palma +9 more
TL;DR: The aim of this study was to compare long‐term clinical outcomes in patients treated with new‐generation drug‐eluting stent (DES) or early‐generation DES in a real‐world registry.